Stanford wants Secukinumab trialists

A clinical trial at Stanford Dermatology is seeking trialists to join a study looking at Secukinumab as a treatment for the papules and pustules, and redness associated with rosacea. If you are interested, and meet the requirements for the trial, please contact them via their details below. What is Secukinumab? Secukinumab (brand name Cosentyx) has recently become […]

Rhofade scores a mention in The New York Times

Allergan will be pleased to discover that they scored a free (one presumes) mention of their Rhofade product in the New York Times Fashion & Style section today. Given that Rhofade is a prescription item, this amounts to publicity of the sort that they cannot buy. How to Go Makeup-Free This Summer By CRYSTAL MARTIN AUG. 1, […]